Citius Oncology CTOR
NASDAQ CTOR
$0.68 -0.02 (-2.51%)
As of: Oct 23, 2026 · 1:22 PM EDT

Citius Oncology (CTOR) Net Cash Flow (2023 - 2026)

Updated

Citius Oncology (CTOR) posted Net Cash Flow of $13.93 million for fiscal Q3 2026 (quarter ended Jun 30, 2026).

Analysis

Citius Oncology (CTOR) Net Cash Flow (2023 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Cash Flow at Citius Oncology was $12.61 million; for FY2025 (ended Sep 30, 2025), it was $3.92 million.

  • Annual Net Cash Flow shows a three-year compound annual growth rate of 138.5% (FY2022 to FY2025).
  • In prior fiscal years, Citius Oncology's Net Cash Flow was $112.00 in FY2024, -$256,429 in FY2023 and $289,175 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF (Qtr)
1 Eli Lilly 1,133.17 Bn 1,101.76 Bn 19.71 Bn 3.72 Bn
2 Johnson & Johnson 634.79 Bn 554.65 Bn 17.30 Bn -3.52 Bn
3 AbbVie 506.40 Bn 479.51 Bn 12.70 Bn -2.82 Bn
4 Merck 357.93 Bn 312.31 Bn 12.21 Bn 1.53 Bn
5 Novartis Ag 292.69 Bn 256.68 Bn 11.24 Bn 757.00 Mn
6 Astrazeneca 265.19 Bn 238.87 Bn 12.86 Bn -3.94 Bn
7 Amgen 238.22 Bn 193.61 Bn 7.24 Bn 1.95 Bn
8 Gilead Sciences 195.23 Bn 169.43 Bn 6.22 Bn -4.43 Bn
9 Pfizer 171.11 Bn 117.76 Bn 10.94 Bn -722.00 Mn
10 Citius Oncology 73.57 Mn 43.15 Mn 1.00 Mn 13.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.93 Mn
Mar 31, 2026 -4.66 Mn
Dec 31, 2025 3.37 Mn
Jun 30, 2024 -33,069.00
Mar 31, 2024 584.00
Jun 30, 2023 -100,256.00
Mar 31, 2023 -168,799.00
API Access

Citius Oncology Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=CTOR&period=max&api_key=YOUR_API_KEY